Global Lymphoma Antibody Drug Conjugates Market 2030: Pipeline, Patents, Prices, Approved Sales, and Clinical Trial Insights Lymphoma Antibody Drug Conjugates Market Opportunity, Patent, Price, Approved Drug Sales & Clinical Trials…
Presto Dental Opens Flagship Multi-Specialty Practice in Bridgeport, Expanding Abra Health Group’s Connecticut Presence Presto Dental, a new and innovative dental brand affiliated with the Abra Health Group, has officially…
BUILT Biotechnologies Named Anchor Company at Commonwealth BioAccelerator, Scaling DNA Manufacturing-as-a-Service to Meet Surging Demand BUILT Biotechnologies,a rapidly emerging leader in DNA Manufacturing-as-a-Service, has announced its selection as an anchor…
Global Molecular Diagnostics Market Set to Reach $30.9 Billion by 2035: Industry Trends, Technologies, and Key Players Molecular Diagnostics Market Industry Trends and Global Forecasts to 2035: Distribution by Test…
Alpha Cognition Inc. Announces Pricing of $35 Million Oversubscribed Public Offering of Common Shares Alpha Cognition Inc. (Nasdaq: ACOG) (the “Company”), a commercial-stage biopharmaceutical company committed to advancing innovative therapies…
LEO Pharma a leading global company in medical dermatology LEO Pharma, a leading global company in medical dermatology, has successfully finalized its acquisition of Spevigo® from Boehringer Ingelheim, as officially…
FIRE1’s Norm System and Congestion Score Highlighted as Late-Breaking Science at HFSA 2025 FIRE1, a pioneering company in connected medical device solutions, has announced that its innovative heart failure management…
Merck Reports Clinical Positive Phase 3 HYPERION Trial Results for WINREVAIR™ (sotatercept-csrk) in Newly Diagnosed Pulmonary Arterial Hypertension Patients Merck known as MSD outside the United States and Canada, today…
Endeavor BioMedicines Reports Positive Phase 2a Results for Taladegib in Idiopathic Pulmonary Fibrosis, Published in The Lancet Respiratory Medicine Endeavor BioMedicines (“Endeavor”), a clinical-stage biotechnology company focused on developing transformative…
Alnylam Pharmaceuticals Reports HELIOS-B Phase 3 Findings: Vutrisiran Reduces Gastrointestinal Events in ATTR-CM Patients Alnylam Pharmaceuticals, Inc. , a global leader in RNA interference (RNAi) therapeutics, today unveiled new analyses…
Balchem Kicks Off New Era of Consumer Engagement: Showcasing the Power of Vitamin K2 at FC Bayern Women’s Season Opener When tens of thousands of fans poured into Munich’s Allianz…
International Day of Older Persons: AOP Health Brings Urgent Attention to the Silent Burden of Venous Leg Ulcers Every year on October 1, the world observes the United Nations’ International…